CAR-T Therapy Target Proteins
CAR receptor molecules are genetically engineered to activate T lymphocytes and achieve an antitumour response. CAR-T therapy represents a significant advance in cancer treatment, with ongoing research into new therapeutic targets, the most common being CD19 and BCMA. These proteins are crucial for the development and effectiveness of CAR-T therapies, offering new hope for patients with certain types of cancer. At CymitQuimica, we provide a wide range of high-quality CAR-T therapy target proteins to support your research and clinical applications.
Found 446 products of "CAR-T Therapy Target Proteins"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
